Hai‐Qiang Mai

机构：Sun Yat-sen University, Sun Yat-sen University Cancer Center · ORCID：0000-0001-6735-8670

发表论文 88 篇 · 总被引 2416 次 · h-index 22

代表论文

• Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma (2023 · JAMA · 被引 254)
• Ninth Version of the AJCC and UICC Nasopharyngeal Cancer TNM Staging Classification (2024 · JAMA Oncology · 被引 115)
• Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial (2024 · The Lancet Oncology · 被引 65)
• International Consensus Guideline on Delineation of the Clinical Target Volumes at Different Dose Levels for Nasopharyngeal Carcinoma (2024 Version) (2025 · International Journal of Radiation Oncology*Biology*Physics · 被引 20)
• Combined pre-treatment and middle-treatment Epstein–Barr virus DNA load contributes to prognostication and treatment modification in nasopharyngeal carcinoma patients (2024 · Therapeutic Advances in Medical Oncology · 被引 14)
• Target volume delineation of the neck for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlas (2025 · The Lancet Oncology · 被引 13)